Predictions
Bpost S.A. A
Start price
Target price
Perf. (%)
€7.62
27.12.21
27.12.21
-
27.12.25
27.12.25
-56.82%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€19.00
27.12.21
27.12.21
-
27.12.22
27.12.22
8.55%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€143.65
27.12.21
27.12.21
-
27.12.22
27.12.22
-9.78%
09.01.22
09.01.22
Risky Investment
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
TAL Education Group ADR
Start price
Target price
Perf. (%)
€3.56
27.12.21
27.12.21
-
27.12.22
27.12.22
-14.61%
07.01.22
07.01.22
Risky Investment
New Oriental Education & Technology Group
Start price
Target price
Perf. (%)
€1.75
27.12.21
27.12.21
-
27.12.25
27.12.25
118.29%
23.01.23
23.01.23
Could be worthwhile Investment >10% per year
TAL Education Group ADR
Start price
Target price
Perf. (%)
€3.56
27.12.21
27.12.21
-
27.12.25
27.12.25
166.29%
22.12.22
22.12.22
Could be worthwhile Investment >10% per year
Hapag Lloyd AG
Start price
Target price
Perf. (%)
€259.40
27.12.21
27.12.21
-
27.12.22
27.12.22
-25.48%
28.12.22
28.12.22
Good culture
Some uniques
Could be worthwhile Investment >10% per year
Capable Management
Rational AG
Start price
Target price
Perf. (%)
€899.00
27.12.21
27.12.21
-
27.12.22
27.12.22
-38.15%
28.12.22
28.12.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€21.63
27.12.21
27.12.21
-
27.12.22
27.12.22
1.73%
09.01.22
09.01.22
New Oriental Education & Technology Group ADR
Start price
Target price
Perf. (%)
€17.90
27.12.21
27.12.21
-
18.01.25
18.01.25
57.54%
26.08.22
26.08.22
BioNTech SE ADR
Start price
Target price
Perf. (%)
€228.00
25.12.21
25.12.21
€260.00
25.12.22
25.12.22
-15.86%
06.01.22
06.01.22
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
Moderna Inc.
Start price
Target price
Perf. (%)
€224.75
25.12.21
25.12.21
€260.00
25.12.22
25.12.22
-14.41%
06.01.22
06.01.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business